Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • QBTS vs MRNA✓SelectedUSD · MRNAQBTS vs MRNA performance historyLatest closeAs of-4.83%11/18
Stock and ETF performance explorer

QBTS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-67.2%
MRNA return
+688.7%
Excess return
-755.9%
Maximum drawdown
-76.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-4.8%-4.8%0.0%-4.5%
7D-27.8%-20.9%-6.9%-26.6%
30D-35.0%-13.3%-21.7%-34.2%
3M-60.6%+212.6%-273.2%-64.2%
6M-59.7%+309.0%-368.7%-68.1%
YTD-70.6%+567.3%-637.9%-82.8%
All-67.2%+688.7%-755.9%-82.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling